Skip to main content
. 2009 Jan 14;24(6):1766–1773. doi: 10.1093/ndt/gfn736

Fig. 4.

Fig. 4

Effect of phenylarsine oxide (PAO) on SHP-1 activity in normal glucose or high glucose. (A) The effect of Ang-(1–7) (10−7 M) on SHP-1 activity in normal glucose is depicted (NG, 5 mM) with or without PAO (10−7 M). *P < 0.001 versus control, **P < 0.001 versus Ang-(1–7); n = 3. (B) The effect of Ang-(1–7) (10−7 M) on SHP-1 activity in high glucose is depicted (HG, 25 mM) with or without PAO (10−7 M). *P < 0.01 versus control, **P < 0.05 versus Ang-(1–7); n = 5. Results are presented in arbitrary units.